Oestrogen inhibits human colonic motility by a non-genomic cell membrane receptor-dependent mechanism

A M Hogan1, R Kennelly, D Collins

  • 1Institute for Clinical Outcomes Research and Education, St Vincent's University Hospital, Dublin, Ireland.

Abstract

Insights

Oestrogen significantly reduces human colon muscle contractions through a rapid, non-genomic pathway. This finding may explain gastrointestinal symptoms in women related to oestrogen levels.

Area of Science:

  • Endocrinology
  • Gastroenterology
  • Pharmacology

Background:

  • Classical oestrogen effects involve nuclear receptor binding and gene activation.
  • Rapid, non-genomic oestrogenic effects bypassing DNA transcription are known.
  • The impact of oestrogen on colonic motility remains largely uncharacterized.

Purpose of the Study:

  • To investigate the effect of oestrogen on human colonic smooth muscle contractility.
  • To determine if the effect is genomic or non-genomic.
  • To explore the mechanism of oestrogen action on the colon.

Main Methods:

  • Human colon smooth muscle strips were isolated and mounted in organ baths.
  • Strips were exposed to 17beta-oestradiol or BSA-conjugated 17beta-oestradiol.
  • Contractile responses to carbachol were measured in the presence or absence of oestrogen receptor antagonist (fulvestrant) or protein synthesis inhibitors.

Main Results:

  • Oestrogen significantly inhibited colonic smooth muscle contractility (P < 0.001).
  • The inhibitory effect was rapid, reversible, and occurred with both forms of oestrogen.
  • The effect was not altered by cycloheximide but was inhibited by fulvestrant, indicating receptor mediation.

Conclusions:

  • Oestrogen decreases contractility in human colonic smooth muscle.
  • The mechanism is non-genomic, involving cell membrane coupling.
  • This rapid action suggests a role for oestrogen in modulating colonic motility.

Related Concept Videos

Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...